Porovnat metody

	Wellsův skóre pro DVT	Skóre CHA₂DS₂-VASc	Skóre qSOFA
Obor	Klinická diagnostika	Klinická diagnostika	Klinická diagnostika
Rodina	Process / pipeline	Process / pipeline	Process / pipeline
Rok vzniku	1994	2010	2016
Tvůrce	Philip S. Wells	Gregory Y. H. Lip, Robby Nieuwlaat, et al.	Sepsis-3 Taskforce
Typ	Venous thromboembolism risk stratification	Atrial fibrillation stroke risk stratification	Rapid sepsis screening
Původní zdroj	Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546.	Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272.	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.
Další názvy	Wells DVT Score, DVT Wells	CHA2DS2VASc, Atrial fibrillation stroke risk	Quick SOFA, qSOFA
Příbuzné	3	3	3
Shrnutí	The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients.	The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions.	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.